AKT1 and glioblastoma: Studies on curcumin derivatives—demethoxycurcumin (DMC) and bisdemethoxycurcumin (BDMC) (Figure 3)—showed that they exhibit similar inhibitory effects on the PI3K/Akt pathway in GBM cells [91,92].